Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
Your comments are welcome:
submit feedback
|
|
Disclosure reporting details |
Back to search detail summary
|
:
01/01/2019 - 06/30/2019
|
Authorizing Officer name
|
John
F.
Heffernan
|
Title
|
Principal
|
Business name
|
Park Street Strategies, LLC
|
Address
|
15 Clifton Avenue
|
City, state, zip code
|
Marblehead, MA 01945
|
Country
|
USA
|
Phone
|
617-981-0015
|
|
|
Client Compensation
|
Biotechnology Innovation Organization (BIO) |
$20,000.00
|
UCB, Inc. |
$21,000.00
|
Massachusetts Biotechnology Council |
$60,000.00
|
Shire |
$30,000.00
|
Flexion Therapeutics, Inc. |
$30,000.00
|
Total salaries received |
$161,000.00
|
|
|
|
Compensation/Salaries Paid
|
John F. Heffernan
|
$0.00
|
Total salaries paid |
$0.00
|
|
|
Activities, Bill Numbers and Titles
|
No activities, bill numbers or bill titles were disclosed for this reporting period. |
|
|
Operating Expenses
|
06/30/2019 |
Staples
|
Photocopies, scans
|
$49.81
|
05/30/2019 |
New England Council
|
Professional dues
|
$1,000.00
|
02/01/2019 |
Riley & Dever
|
Legal fees
|
$670.00
|
06/30/2019 |
US Postal Service
|
Postage, shipping, delivery
|
$86.43
|
06/30/2019 |
Regus
|
Rent
|
$1,065.00
|
06/30/2019 |
AT&T
|
Telephone, cell phone, handheld
|
$642.78
|
03/27/2019 |
Ward & Lawless LLC
|
Other operating expenses
|
$1,264.00
|
| | Total operating expenses |
$4,778.02
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|
|
Lobbyist: John F. Heffernan
|
Client:
Biotechnology Innovation Organization (BIO)
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
2666
|
An Act designating the last day of February as rare disease day in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
652
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1235
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1088
|
An Act relative to prescription drug access
|
Support
|
$0.00
|
N/A
|
House Bill
|
1934
|
An Act to create a Massachusetts rare disease advisory council
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
640
|
An Act to ensure access to generic medications
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1218
|
An Act relative to sharps stewardship
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3481
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
653
|
An Act relative to prescription drug pricing
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1295
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
229
|
An Act to protect innovation and entrepreneurship in the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
1154
|
An Act to reduce drug costs through transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3500
|
An Act to protect children, families, and firefighters from harmful flame retardants
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
654
|
An Act to strengthen pharmacy benefit management
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1301
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
949
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
541
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Docket
|
2264
|
An Act to create a Massachusetts rare disease advisory council
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
391
|
An Act relative to reprogrammed human skin cells for embryonic stem cell research
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1660
|
An Act promoting pay transparency and pipeline advancement
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
3551
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
695
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1304
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
966
|
An Act to promote value-based insurance design in the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1192
|
An Act relative to the examination of health care cost trends in MassHealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
552
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
721
|
An Act relative to mandatory prescription drug coverage
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
916
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
House Bill
|
1168
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
159
|
An Act to protect innovation and entrepreneurship in the Commonwealth
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1879
|
An Act to ensure more women serve on corporate boards of directors
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
915
|
An Act ensuring access to medications
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1167
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
154
|
An Act relative to bad faith assertions of patent infringement
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
703
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1780
|
An Act relative to repealing the Employer Medical Assistance Contribution Supplement Tax
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
629
|
An Act relative to pharmaceutical pricing
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3654
|
An Act relative to compensation for victims of opioids
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1701
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1
|
making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1062
|
An Act relative to transparent health care data
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1930
|
An Act providing for unused medication return by health care facilities
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
611
|
An Act to promote value-based insurance design in the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1206
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
1055
|
An Act to ensure access to generic medications
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1860
|
An Act relative to the dispensing of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
601
|
An Act to reduce the cost of pharmacy benefits
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1149
|
An Act strengthening prescription drug safety and drug stewardship
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1016
|
An Act establishing a commission to study maximum allowable costs lists
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1853
|
An Act relative to fail first and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
582
|
An Act ensuring access to medications
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
733
|
An Act relative to consumer protection for prescription drug purchases
|
Support
|
$0.00
|
N/A
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1111
|
An Act allowing for retail pharmacy discounts and co-pay assistance
|
Support
|
$0.00
|
N/A
|
House Bill
|
1972
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
646
|
An Act to strengthen pharmacy benefit management
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1230
|
An Act to protect children, families, and firefighters from harmful flame retardants
|
Support
|
$0.00
|
N/A
|
House Bill
|
959
|
An Act requiring continual coverage of prescription medication
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1186
|
An Act strengthening HPC and CHIA market oversight
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
543
|
An Act reducing health care costs through improved medication management
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
715
|
An Act relative to pharmaceutical price transparency and cost sharing
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1013
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
570
|
An Act relative to out-of-pocket expenses for prescription drug coverage
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
728
|
An Act providing affordable access to generic medicines
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F. Heffernan
|
House Bill
|
1088
|
An Act relative to prescription drug access
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1295
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
916
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1206
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
1111
|
An Act allowing for retail pharmacy discounts and co-pay assistance
|
Support
|
$0.00
|
N/A
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1167
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1853
|
An Act relative to fail first and patient safety
|
Support
|
$0.00
|
N/A
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1660
|
An Act promoting pay transparency and pipeline advancement
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1154
|
An Act to reduce drug costs through transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
629
|
An Act relative to pharmaceutical pricing
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
715
|
An Act relative to pharmaceutical price transparency and cost sharing
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
541
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
House Bill
|
959
|
An Act requiring continual coverage of prescription medication
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1235
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
House Bill
|
1
|
making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
3481
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F. Heffernan
|
Client:
Massachusetts Biotechnology Council
|
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3481
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
601
|
An Act to reduce the cost of pharmacy benefits
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1149
|
An Act strengthening prescription drug safety and drug stewardship
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1088
|
An Act relative to prescription drug access
|
Support
|
$0.00
|
N/A
|
House Bill
|
1972
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
570
|
An Act relative to out-of-pocket expenses for prescription drug coverage
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
728
|
An Act providing affordable access to generic medicines
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1
|
making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3500
|
An Act to protect children, families, and firefighters from harmful flame retardants
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
611
|
An Act to promote value-based insurance design in the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1206
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
229
|
An Act to protect innovation and entrepreneurship in the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
1154
|
An Act to reduce drug costs through transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3551
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
640
|
An Act to ensure access to generic medications
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1218
|
An Act relative to sharps stewardship
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
949
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
House Bill
|
1186
|
An Act strengthening HPC and CHIA market oversight
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
3877
|
Relative to capping the price of life saving prescription drugs
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
695
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1304
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
391
|
An Act relative to reprogrammed human skin cells for embryonic stem cell research
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3654
|
An Act relative to compensation for victims of opioids
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
646
|
An Act to strengthen pharmacy benefit management
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1230
|
An Act to protect children, families, and firefighters from harmful flame retardants
|
Support
|
$0.00
|
N/A
|
House Bill
|
966
|
An Act to promote value-based insurance design in the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
154
|
An Act relative to bad faith assertions of patent infringement
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
703
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1780
|
An Act relative to repealing the Employer Medical Assistance Contribution Supplement Tax
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
916
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
House Bill
|
1660
|
An Act promoting pay transparency and pipeline advancement
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
654
|
An Act to strengthen pharmacy benefit management
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1301
|
An Act to prevent undue influence on prescriber behavior
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
915
|
An Act ensuring access to medications
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1168
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
653
|
An Act relative to prescription drug pricing
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
1295
|
An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
629
|
An Act relative to pharmaceutical pricing
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1167
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
652
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
1235
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
House Bill
|
1062
|
An Act relative to transparent health care data
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1934
|
An Act to create a Massachusetts rare disease advisory council
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
552
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
721
|
An Act relative to mandatory prescription drug coverage
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Monitoring the Health Policy Commission implementation of Chapter 363 of the Acts of 2018, An Act Extending the Authorization for the use of certain discount vouchers for prescription drugs
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1055
|
An Act to ensure access to generic medications
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1930
|
An Act providing for unused medication return by health care facilities
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
543
|
An Act reducing health care costs through improved medication management
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
715
|
An Act relative to pharmaceutical price transparency and cost sharing
|
Neutral
|
$0.00
|
N/A
|
Senate Docket
|
2264
|
An Act to create a Massachusetts rare disease advisory council
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1016
|
An Act establishing a commission to study maximum allowable costs lists
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1860
|
An Act relative to the dispensing of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
541
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1111
|
An Act allowing for retail pharmacy discounts and co-pay assistance
|
Support
|
$0.00
|
N/A
|
House Bill
|
2666
|
An Act designating the last day of February as rare disease day in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
582
|
An Act ensuring access to medications
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
733
|
An Act relative to consumer protection for prescription drug purchases
|
Support
|
$0.00
|
N/A
|
House Bill
|
959
|
An Act requiring continual coverage of prescription medication
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1192
|
An Act relative to the examination of health care cost trends in MassHealth
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1701
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1013
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
House Bill
|
1853
|
An Act relative to fail first and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
159
|
An Act to protect innovation and entrepreneurship in the Commonwealth
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1879
|
An Act to ensure more women serve on corporate boards of directors
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F. Heffernan
|
House Bill
|
916
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
629
|
An Act relative to pharmaceutical pricing
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3551
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
949
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
959
|
An Act requiring continual coverage of prescription medication
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
541
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
House Bill
|
1660
|
An Act promoting pay transparency and pipeline advancement
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1088
|
An Act relative to prescription drug access
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
552
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1167
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1206
|
An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
1154
|
An Act to reduce drug costs through transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
696
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
695
|
An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
570
|
An Act relative to out-of-pocket expenses for prescription drug coverage
|
Support
|
$0.00
|
N/A
|
House Bill
|
2666
|
An Act designating the last day of February as rare disease day in the Commonwealth
|
Support
|
$0.00
|
N/A
|
House Bill
|
1
|
making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1972
|
An Act to permit the wholesale importation of prescription drugs into the Commonwealth
|
Oppose
|
$0.00
|
N/A
|
Senate Docket
|
2264
|
An Act to create a Massachusetts rare disease advisory council
|
Support
|
$0.00
|
N/A
|
House Bill
|
1934
|
An Act to create a Massachusetts rare disease advisory council
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
915
|
An Act ensuring access to medications
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
712
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1304
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
Lobbyist: John F. Heffernan
|
Client:
Flexion Therapeutics, Inc.
|
|
House Bill
|
3800
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Executive
|
Department of Public Health (DPH)
|
Monitoring Department of Public Health opioid regulations
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
3801
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
2235
|
An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1
|
making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
Meals, Travel, and Entertainment Expenses
|
04/08/2019 | John F. Heffernan |
Meal
|
Catalyst Restaurant, Cambridge, MA
|
John Heffernan;Pat Cerundol
|
$43.31
|
01/28/2019 | John F. Heffernan |
Meal
|
Bell in Hand, Boston, MA
|
John Heffernan;Brian O'Connor;Brian Johnston
|
$136.28
|
06/25/2019 | John F. Heffernan |
Travel
|
Parking at 100 Hancock Street, Quincy, MA
|
John Heffernan
|
$2.25
|
02/20/2019 | John F. Heffernan |
Travel
|
Uber (from 100 Cambridge St, Boston, MA to 300 Technology Square, Cambridge, MA)
|
John Heffernan
|
$10.50
|
04/08/2019 | John F. Heffernan |
Travel
|
Parking at Technology Square, Cambridge, MA
|
John Heffernan
|
$38.00
|
06/19/2019 | John F. Heffernan |
Travel
|
Parking at PI Alley Garage, Boston, MA
|
John Heffernan
|
$41.00
|
06/25/2019 | John F. Heffernan |
Travel
|
Uber (from 15 Clifton Ave, Marblehead, MA to 300 Technology Square, Cambridge, MA)
|
John Heffernan
|
$44.96
|
| | | | Total amount |
$316.30
|
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
03/19/2019 | John F. Heffernan |
Ronald Mariano
|
State Representative
|
$200.00
|
03/28/2019 | John F. Heffernan |
Michael Moran
|
State Representative
|
$200.00
|
04/02/2019 | John F. Heffernan |
Karen Spilka
|
State Senate
|
$200.00
|
04/11/2019 | John F. Heffernan |
Dvid Biele
|
State Representative
|
$200.00
|
04/11/2019 | John F. Heffernan |
John Mahoney
|
State Representative
|
$200.00
|
04/11/2019 | John F. Heffernan |
Jennifer Benson
|
State Representative
|
$200.00
|
04/16/2019 | John F. Heffernan |
Edward Coppinger
|
State Representative
|
$200.00
|
05/08/2019 | John F. Heffernan |
Michael Rodrigues
|
State Senate
|
$200.00
|
05/08/2019 | John F. Heffernan |
Adam Hinds
|
State Senate
|
$200.00
|
05/14/2019 | John F. Heffernan |
Michael Moore
|
State Senate
|
$200.00
|
05/14/2019 | John F. Heffernan |
Jason Lewis
|
State Senate
|
$200.00
|
05/21/2019 | John F. Heffernan |
Mark Cusack
|
State Representative
|
$200.00
|
05/21/2019 | John F. Heffernan |
Michael Day
|
State Representative
|
$200.00
|
05/22/2019 | John F. Heffernan |
Paul Tucker
|
State Representative
|
$200.00
|
05/22/2019 | John F. Heffernan |
William Driscoll
|
State Representative
|
$200.00
|
06/18/2019 | John F. Heffernan |
Patricia Haddad
|
State Representative
|
$200.00
|
| | | Total contributions |
$3,200.00
|
|
|
|
|
|